Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

ReCode Therapeutics

Main focus: Treatment of genetic diseases

Company stage: Pre-clinical

Diseases: Cystic fibrosis, genetic diseases

Genome editing tool: CRISPR

Funding stage: Private

Location: Menlo Park, CA, USA

Website: https://recodetx.com/

Pipeline: https://recodetx.com/pipeline/

ReCode Therapeutics is mainly focused on treating genetic diseases using its mRNA technologies. However, the company is also pursuring gene-editing modalities, which it is able to deliver using proprietary technologies. The company's lead gene-editing programmes have yet to be disclosed.

Tags

HashtagReCode Therapeutics

Company: ReCode Therapeutics
close
Search CRISPR Medicine